RMS: Extended ofatumumab treatment presents favorable benefit-risk profile in ALITHIOS studyMarch 21, 2022Multiple Sclerosis
Multiple sclerosis: Discontinuing fingolimod improves humoral response after SARS-CoV-2 vaccinationMarch 21, 2022Multiple Sclerosis
Flu vaccination does not increase risk for infections or relapse in MSMarch 21, 2022Multiple Sclerosis
Masitinib at 4.5 mg/kg/day shows promise in progressive forms of multiple sclerosis March 21, 2022Multiple Sclerosis
Plasma S100A12 and Apo-A1 levels in untreated RRMS patients and their at-risk family membersMarch 21, 2022Multiple Sclerosis
BCG vaccination and risk for relapsing-remitting MS: Is there a link?March 21, 2022Multiple Sclerosis
Is sNfL an effective biomarker for neuronal damage and drug response in MS?March 21, 2022Multiple Sclerosis
